Evaluation of drug usage and expenditure in a hospital diabetes clinic

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 1, 1998, Pages 49-56

  Wu, S Y B ^a   Lung, B C H ^a   Chang, S ^a   Lee, S C ^b   Critchley, J A J H ^a   Chan, J C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; GLIBENCLAMIDE; GLICLAZIDE; INSULIN; LOOP DIURETIC AGENT; METFORMIN; NICOTINIC ACID; SIMVASTATIN; SULFONYLUREA; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG COST; DRUG USE; FEMALE; HEALTH CARE FINANCING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; QUALITY OF LIFE;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG UTILIZATION REVIEW; FEMALE; HONG KONG; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; SEX FACTORS;

EID: 0031872680     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00138.x     Document Type: Article

References (33)

1. Zimmet P. (1992) Challenges in diabetes epidemiology-from West to the rest. Diabetes Care, 15, 232-252.
2. Cockram CS, Woo J, Lau E, et al. (1993) The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Research and Clinical Practice, 21, 67-73.
3. Woo J, Swaminathan R, Cockram CS, Pang CP, Mak YT, Au SY. (1987) The prevalence of diabetes mellitus and an assessment of methods of detection among a community of elderly Chinese in Hong Kong. Diabetologia, 30, 863-868.
4. Chan JCN, Cheung JCK, Lau EMC, Woo J, Swaminathan R, Cockram CS. (1996) The Metabolic Syndrome in Hong Kong Chinese - the inter-relationships amongst its components analysed by structural equation modeling. Diabetes Care, 19, 953-959.
5. Chan JCN, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS. (1993) Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgraduate Medicine, 69, 204-210.
6. Lau GSN, Chan JCN, Chu PLM, Tse DCK, Critchley JAJH. (1996) Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong. Annals of Pharmacotherapy, 30, 232-237.
7. Kubin RJ, Altman WM, Mendelson DN. (1994) Health care expenditures for people with diabetes mellitus, 1992. Journal of Clinical Endocrinology and Metabolism, 78, 809A-809F.
8. Mehta DK (ed) (1997) Cardiovascular System. In: British National Formulary. Number 33, p. 60-101, 113-117, The Pharmaceutical Press, London.
9. Mehta DK (ed) (1997) Endocrine System. In: British National Formulary. Number 33, pp. 289-301, The Pharmaceutical Press, London.
10. Chou P, Chen HH, Hsiao KJ. (1992) Community-based epidemiological study on diabetes in Pu-Li, Taiwan. Diabetes Care, 15, 81-89.
11. Ko GTC, Chan JCN, Woo J, et al. (1997) The effects of age on cardiovascular risk factors in Chinese women. International Journal of Cardiology, 61, 221-227.
12. Ferner RE, Neil HAW. (1988) Sulphonylureas and hypoglycaemia. British Medical Journal, 296, 949-950.
13. Gerich JH. (1989) Oral hypoglycemic agents. New England Journal of Medicine, 321, 1231-1245.
14. Chan TYK, Chan JCN, Critchley JAJH. (1992) Severe hypoglycaemia in Chinese patients with non-insulin-dependent diabetes treated with insulin or sulphonylureas. Pharmacoepidemiology and Drug Safety, 1, 207-211.
15. Bailey CJ. (1992) Biguanides and NIDDM. Diabetes Care, 15, 755-772.
16. U.K. Prospective Diabetes Study Group. (1995) U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy for Type II diabetes: a progressive disease. Diabetes, 44, 1249-1258.
17. Chow CC, Tsang LWW, Sorensen JP, Cockram CS. (1995) Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NlDDM patients. Diabetes Care, 18, 307-314.
18. Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ. (1992) Is combination sulfonylurea and insulin therapy useful in NIDDM patients: a meta-analysis. Diabetes Care, 15, 953-959.
19. Pfeffer MA, Braunwald E, Moyé LA, et al. on behalf of the SAVK investigators. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. New England Journal of Medicine, 327, 669-677.
20. Lewis EJ, Hunsicker LC, Bain RP, Rohde RD. (1993) The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. NCTC England Journal of Medicine, 329, 1456-1462.
21. Bühler FR, Kiowski W. (1487) Calcium antagonists in hypertension. Journal of Hypertension, 5 (Suppl. 3), 3-10.
22. Brouhard BH. (1992) Antihypertensive therapy for patients with diabetes mellitus. Diabetes Care, 15, 925-928.
23. Chan JCN, Cockram CS, Critchley JAJH. (1996) Drug-induced disorders of glucose metabolism-mechanisms and management. Drug Safety, 15, 135-159.
24. Wandell PE, Brorsson B, Aberg H. (1997) Drug prescription in diabetic patients in Stockholm in 1992 and 1995 - change over time. European Journal of Clinical Pharmacology, 52, 249-254.
25. Weidmann P, Ferrari P. (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care, 14, 220-232.
26. Chan JCN, Nicholls C, Cheung CK, Law LK, Swaminathan R, Cockram CS. (1995) Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. Diabetes Care, 18, 1001-1006.
27. Reaven GM, Greenfield MS. (1981) Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes, 20 (Suppl. 2), 66-75.
28. Scandinavian Simvastatin Survival Study Group. (1995) Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet, 345, 1274-1275.
29. Pyörälä K, Pedersen TR, Kjekshus J, et al. (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care, 20, 614-620.
30. Chan JCN, Tomlinson B, Nicholls MG, Swaminathan R, Cheung CK, Cockram CS. (1996) Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non-insulin-dependent diabetes (NIDDM). Diabetic Medicine, 13, 150-155.
31. Ramsay LH, Haq IU, Jackson PR, Yw WW, Pickin DM, Payne JN. (1996) Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet, 348, 387-388.
32. The Diabetes Control and Complications Trial Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986.
33. Chan JCN, Cockram CS. (1997) Diabetes mellitus in Chinese and its implications on health cost. Diabetes Care, 20, 1785-1790.